Diabetes Drugs To Feature Black Box Warning
Just days after deciding not to pull GlaxoSmithKline PLC's Avandia Type 2 diabetes drug from the shelves, the U.S. Food and Drug Administration has instead gotten the company and other manufacturers...To view the full article, register now.
Already a subscriber? Click here to view full article